Patients With B Cell ALL, Relapsed or Refractory, With no Available Curative Treatment Options

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB13881Tisagenlecleucel2Completed1